Skip to main content

Stefan G Sarafianos

NIH Rank #3083
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8742873Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pediatrics

NIH Funding · FY2025

Linked Award Amount
$3.2M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#3,083
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Stefan G Sarafianos. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Stefan G Sarafianos as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI177696-02R01
    Discovery of Antivirals Targeting Mpox Virus
    $767.1K
    award amount
  • 5R01AI167356-04R01
    Discovery of SARS-CoV-2 antivirals using a replicon assay
    $695.1K
    award amount
  • 4R37AI076119-17R37
    Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIV
    $626.4K
    award amount
  • 5U54AI170855-04U54
    Behavior of HIV in Viral Environments (B-HIVE)
    $574.1K
    award amount
  • 5R01AI120860-11R01
    Development of HIV capsid-targeting antivirals that affect immune response by modulating capsid stability and have improved resistance profiles
    $526.6K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Stefan G Sarafianos as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Emory University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1948
  6. 2024
    Entered Top 25% Nationally
    Ranked #1948
  7. 2024
    Entered Top 10% Nationally
    Ranked #1948
  8. 2025
    $5M Cumulative Funding
  9. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  10. 2025
    R01 Grant Holder
  11. 2025
    Program/Center Grant Leader
  12. 2026
    $10M Cumulative Funding